SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

August 24, 2024
Conferences SABCS 2023
Conferences SABCS 2023
Share This:

Key Points

NSABP B-51 – Loco-regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node Negative After Neoadjuvant Chemotherapy
IDEA Update – Five-year Outcomes of the IDEA trial of Endocrine Therapy Without Radiotherapy After Breast-Conserving Surgery for Postmenopausal Patients Aged 50-69 With Genomically-Selected Favorable Stage I Breast Cancer
ICARO – Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated with Axillary Dissection or Nodal Radiation
Keynote-522 Update – Event Free Survival with neoadjuvant and adjuvant pembrolizumab in TNBC
Dr. Eleonora Teplinsky
Profile

Dr. Eleonora Teplinsky covering the San Antonio Breast Cancer Symposium 2023

In discussion with Dr. Eleonora Teplinsky covering the San Antonio Breast Cancer Symposium 2023 Highlights from Community Oncology perspective. We covered 4 important practice informing studies with Dr. Teplinsky

 

Tags:
SABCS 2023 Breast Cancer Keynote 522 Update IDEA Update NSABP

Related Posts

Conferences GI ASCO August 24, 2024
GI ASCO 2023 Highlights with Dr. Mark Lewis
Conferences GU ASCO 2024 August 24, 2024
GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564

This website uses Cookies to ensure you receive the best experience.